Farmas USA

IBB: Approaching Escape Velocity?

http://seekingalpha.com/article/3993898-ibb-approaching-escape-velocity

GlaxoSmithKline is teaming up with Alphabet's (GOOG, GOOGL) Verily Life Sciences unit to develop bioelectronic medicines, or treatments that use miniature electronic devices to modify how impulses are transmitted around the nervous system. The pair will spend up to £540M over seven years on the venture, called Galvani Bioelectronics, provided they succeed in hitting various milestones along the way. GSK +0.6% premarket.

$heff envía también hoy este vídeo de un analista de RBC Capital Markets sobre el potencial de subida de la biotecnología

http://link.brightcove.com/services/player/bcpid3749314076001?bckey=AQ~~,AAADUgsjclE~,KW_GhQxgNeRs_P7qKJJZZnyR-uupeTzA&bctid=5063160457001

Premarket 291 

breakout :)

IBB

Muchas buenas noticias esta mañana. IONS, SGEN. Debería ayudar.

AMRN
Algo se debe estar cociendo, después de la subida del viernes y las últimas semanas alcistas, hoy PM subiendo un 6%... no muchos cromos pero está casi en mi verde!!!

Me he perdido algo aparte de resultados el día 4??

hombre, que los interim data de Reduce-it estan al caer
AMRN

AMRN

No sigo la empresa pero he leido esto , por si os sirve.

Patent and Trademark Office has received Amarin Pharmaceuticals Ireland's patent application for stable pharmaceutical composition and methods of using same. Manku Mehar, Osterloh Ian, Wicker Pierre, Braeckman Rene and Soni Paresh developed the invention.

The patent application number is 15/092391. International Patent Classification code is A61K 31/202 20060101 A61K031/202. Cooperative Patent Classification code is A61K 31/202 20130101.

U.S. Patent and Trademark Office has released the abstract. According to the abstract, "The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases."